Key result
The clinical overlap of NAFLD and CESD was evaluated in a pilot study, though no quantitative results were reported in the abstract.
Observational
May prompt LAL testing in atypical NAFLD; leaves open the true prevalence and clinical impact of CESD overlap.
Objectives: NAFLD is the most evolving global morbidityprogresses tocirrhosis, liver cancer and Transplantation. Clinical Spectrum is heterogeneous with biochemical and histological diversity. CESD is a part of metabolic storage disease with an intrinsic Lysosomal Acid Lipase deficiency (LAL) mimicking clinical overlap with NAFLD This clinical pilot study evaluates the clinical overlap of similar metabolic syndromes with diverse etiology And outcome.
No takes yet. Share an insight, caveat, or question.
Cheung et al. (2013) conducted an observational in Non-alcoholic fatty liver disease (NAFLD) and Cholesteryl ester storage disease (CESD). Clinical overlap of NAFLD and CESD was evaluated. The clinical overlap of NAFLD and CESD was evaluated in a pilot study, though no quantitative results were reported in the abstract.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: